EpiPen Settlement from Viatris (Mylan) for Price Gouging Accusations

The sky high unaffordable pricing for the EpiPen from Mylan, now called Viatris has been settled with a $264 Million agreement reached. Claims can be made through EpiPenClassAction.com Viatris — Formerly Mylan — Agrees to $264 Million Settlement to Settle EpiPen Price Gouging Claims ByDave Bloom -2022/03/07 2585 Share Last week, Viatris — the company formerly known [...]